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Abslraet The substrate properties of four carbocyclic D and L nucleoside 5’-triphosphate nalogs toward HIV and AMV reverse transcriptases and 
terminal deoxynucleotidyl transferase were evaluated. The compounds of the D-B and L-B series were found to be terminating substrates for these 
enzymes, while the derivatives of the o-d and ~-a series were recognized only by terminal deoxynucleotidyl transferase, suggesting that for the 
template-independent enzyme the mutual orientation of the two fragments i  of no significance. A hypothesis for binding of nucleotides tothe DNA 
polymerase active center was proposed. 
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1. Introduction 
The role of the sugar residue in the interaction between 
dNTP and the (template-primer-DNA polymerase) complex 
has been extensively studied. In recent years there has been 
substantial accumulation of data on the effect of substituents 
in the sugar residue, as well as its conformation and, finally, the 
configuration of the nucleoside on the process of binding to 
DNA polymerase [ 1,2]. 2’,3’-Dideoxy-2’,3’-didehydronucleo- 
side 5’-triphosphates have been shown to be substrates for 
retroviral RTs and some other DNA polymerases [3,4]. The 
carboanalogs of these compounds (1,II) displayed similar sub- 
strate properties [5-71. 
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As a rule, dNTP analogs containing a double C2’-C3’ bond 
exhibited high affinity to the DNA synthesizing complex re- 
gardless of what template-primers and DNA polymerases were 
used. Van Draanen et al. have studied the substrate properties 
of the stereomers IIa and III toward HIV RT and shown that 
the L isomer has a 50-fold lower affinity to the enzyme [7J 
*Corresponding author. 
Abbreviations: RT, reverse transcriptase; HIV, human immunodefi- 
ciency virus; AMV, avian myeloblastosis v rus; TdT, terminal deoxynu- 
cleotidyl transferase; dNTP, 2’deoxynucleoside 5’-triphosphate; 
d2NTP, 2’J’dideoxynucleoside 5’-triphosphate. 
We evaluated four carbocyclic dATP analogs containing a 
double C2’-C3’ bond (IIb, IV-VI) as substrates for HIV and 
AMV RTs and TdT using DNA and RNA templates. 
2. Materials and methods 
Triphosphates IIb and IV-VI were synthesized from the correspond- 
ing nucleosides. Synthesis of the nucleosides has been described in [8], 
HIV RT was isolated according to [9], AMV RT and calf thymus TdT 
were from Chnutninsk Chemicals and Amersham, respectively. Phage 
M13mplO DNA was isolated according to [IO]. Heteropolymeric RNA 
was synthesized by run-off transcription of SalGI-digested plasmid 
pPV-19 with T7 RNA polymerase according to [ll]. The plasmid con- 
taining a fragment of pBR322 DNA between the SaZGl and SphI sites 
was a gift of Dr. S. Kochetkov. Primer extension and sequencing assays 
were performed as described in [12]. For kinetic assays, the reaction 
mixture (6 ~1) contained 0.02 PM DNA- primer (Fig. la) or 0.2 PM 
RNA-primer (Fig. 1 b,c) complex, 3units of AMV or HIV RT or 2 units 
of TdT, dNTP or its analog at different concentrations, and the appro- 
priate buffer [12]. The reaction was carried out for 2 min at 37O’C and 
terminated by adding 3 ~1 of formamide with EDTA. The products 
were separated by PAGE, and the autoradiographs were scanned in an 
LKB densitometer. 
3. Results 
The analogs were evaluated as terminating substrates on 
DNA (Fig. la) and RNA (Fig. lc) templates (Fig. 1). Fig. 2 
presents the results of the primer extension assay for dATP, IIb, 
and IV-VI. It can be seen that IIb and IV were efficiently 
incorporated into the DNA chain by HIV RT, whereas VI 
displayed weaker substrate properties and V was not recog- 
nized by the enzyme. A similar picture was observed with the 
RNA template. The results of AMV RT assays were similar but 
V and VI were not incorporated into the DNA chain at all (data 
not shown). 
We also evaluated the ability of IIb and IV to terminate DNA 
synthesis catalyzed by HIV RT on DNA (Fig. Id) and RNA 
(Fig. lb) templates. Fig. 3 presents the termination pattern for 
IIb obtained with complex d. In control assays (lanes 3-10) 
d,NTPs were used as chain terminators. Clearly, DNA synthe- 
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a) d(GGGTCAGTGCTGCAACATTTTGCTGCCGGT...) 
[5'-32P]d(GACGTTGTAAAACG) 
10 20 
b) r(CGAGAGGGAAUACGCUGAGGACGUAA...) 
[5'-32P]d(ATGCGACTCCTGC) 
10 20 
c) r(CGAGAGGGAAUACGCUGAGGACGUAA...) 
[51-32P]d(GCTCTCCCTTATGCGACTCC) 
10 20 30 40 
d) d(GGGTCAGTGCTGCAACATTTTGCTGCCGGTCACGGTTCGA...) 
[5'-32P]d(CCCAGTCACGACGT) 
Fig. 1. Templateprimer complexes used in this work. 
sis is terminated at the IIb/dATP concentration ratio of 2-12. 
Results were similar for IV, both compounds produced similar 
pictures on DNA and RNA templates (data not shown). 
To assess the incorporation quantitatively, we obtained the 
time and concentration dependences of product formation 
using DNA and RNA templates. The time dependence was 
linear up to 4.5 min. The concentration dependence was ob- 
tained at 2 min and used to construct he Lineweaver-Burk plot 
and determine the K,,, values and V,,/I’_(dATP). In some 
control assays (complex c), d,ATP was used instead of dATP 
because otherwise the assay mixture would contain all four 
dNTPs and the nascent chain would be further elongated. The 
K, values for V and VI in RNA-dependent primer extension 
catalyzed by AMV RT ranged from 1.5 to 3.0 PM. 
It can be seen in Fig. 4 that all four tested compounds are 
recognized by TdT and extend the primer chain, IIb and IV 
being better substrates than V and, especially, VI. Kinetic as- 
says with TdT were carried out within the linear portion of the 
kinetic curve, the reaction time was 2 min. The kinetic constants 
for all four compounds in TdT-catalyzed primer extension are 
summarized in Table 2. 
4. Discussion 
Using DNA and RNA templates, we showed that IIb and IV 
are good terminating substrates for AMV and HIV RTs. Their 
X, values are close to each other and rather small, implying 
high affinity of the compounds to RTs. It is noteworthy that 
our data are inconsistent with some results obtained in other 
laboratories. In particular, it has been found that the D isomer 
Ib displays a 50-fold higher affinity to HIV RT than the 
L isomer III [7]. It has been also shown that the L isomer of 
2’-deoxy-3’-thio-5-fluorocytosine 5’-triphosphate is a better 
Fig. 2. Primer extension catalyzed by HIV RT. 1, Template-primer 
(complex a) + enzyme; 2, as 1 + 10 PM dATP; 3, as 1 + 10 PM IIb; 
4,asl+lOO~MIIb;5,asl+l0~MW,6,asl+lOO~MW,7,as 
1 + 10,~M VI; 8, as 1 + 100pM VI; 9, as 1 + 10,~M V, 10, as 1 + 100 
/LM V. 
substrate for HIV RT [ 131 and human hepatitis B virus DNA 
polymerase [l4] than the D isomer. 
The results obtained in this work are in agreement with our 
data on modified dNTPs with conformationally rigid flattened 
glycones [3,5,7] (for more references ee [6]) and support the 
hypothesis that such compounds fit the structure of the RT 
active center modelling the transition state of dNTPs in the 
RT-dNTP complex [ 151. The results presented here, as well as 
our earlier data [3,5,7,15,18-201 indicate that the absence of the 
3’ hydroxyl does not inactivate the nucleotide substrate. 
It seems likely that V and VI are not recognized by RTs. The 
primer extension observed in the presence of these compounds 
is presumably due to the admixture of IIb and IV because the 
difference in the retention times for the IIb-V and IV-VI pairs 
upon HPLC chromatography is about 1 min [8] and their Km 
values differ 50-200-fold. 
At the same time, all four examined compounds were incor- 
porated into the primer chain by TdT and their K, values in 
TdT-catalyzed primer extension differed only slightly. 
Thus, RTs recognize only ‘cis-like’ isomers (IIb and IV), 
while template-independent TdT incorporates both ‘cis-like’ 
(IIb and IV) and ‘truns-like’ isomers (V and VI) into the primer 
chain with a similar efficiency. These data suggest hat for the 
template-independent enzyme, tight fixation of the nucleic base 
with respect o the triphoshate residue is not required. Indeed, 
binding of dNTP to the (TdT-primer) complex does not include 
Watson-Crick pairing. 
Based on the analysis of our results and the data published 
in the literature, we suggest hat the glycone of dNTP functions 
Table 1 
Kinetic constants for IIb and IV in primer extension catalyzed by AMV and HIV RTs 
Enzyme + temnlate-primer _ _ 
AMV RT + complex a AMV RT + complex b AMV RT + complex c HIV RT + complex c 
K,, PM V 
V:(d ATP) 
K,n, PM V mu Knu PM V 
V::(d, ATP) 
KM, PM V 
V,,@ATP) V:(d, ATP) 
IIb 0.03 + 0.004 0.72 0.028 f 0.003 0.63 0.069 f 0.05 1.38 0.021 f 0.002 1.26 
IV 0.019 + 0.002 0.77 0.0076 f 0.0004 0.77 0.014 f 0.001 1.51 0.0034 + 0.001 1.52 
ddATP - 
;.OO 
0.21 + 0.05 0.83 0.19 r 0.03 1 .oo 0.19 + 0.04 1 .oo dATP 1.72 f 0.14 0.034 + 0.003 1 .oo - 
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Table 2 
Kinetic constants for IIb and IV-VI in primer extension catalyzed by 
TdT 
III, IV V VI 
&,, PM 3.1 f: 0.3 5.0 + 0.2 10.1 f. 0.4 5.2 f 0.2 
F,.&‘,.. (IIb) 1 .oo 0.88 0.45 0.76 
only as a framework positioning the nucleic base and the tri- 
phosphate residue correctly relative to each other and does not 
bind to the active center, whereas the latter are directly involved 
in specific binding. The glycone maintains the correct distance 
and torsion angle between the glycoside and C4%5’ bonds, 
thus ensuring efficient binding to RTs. Flattening of the gly- 
cone structure facilitates rotation of the nucleic base with re- 
spect to the glycone, providing thermodynamically more effi- 
cient Watson-Crick pairing [21,22]. 
123456 
Fig. 4. Primer extension catalyzed by TdT. 1, primer + enzyme; 2, as 
1 + 10,~M dATP; 3, as 1 + 1OpM IIb; 4, as 1 + 10,~M IV, 5, as 1 + 10 
flMVI;6,asl+lOpMV. 
Compounds IIb and IV may be useful in designing antiviral 
agents because they, first, display high affinity to HIV RT and, 
second, contain enzymatically nonhydrolyzable bonds between 
the nucleic base, glycone, and triphosphate residue. We are 
currently working on modification of the p and y phosphates 
in IIb and IV that would additionally increase their stability in 
blood. 
It has been shown that the level of TdT in leukocytes of 
leukemia patients is very high [23]. Compounds V and VI 
proved to be specific terminating substrates for TdT. There- 
fore, we are planning to evaluate the corresponding mono- 
phosphonates as inhibitors of TdT in cell cultures. 
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